Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 30% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 2 institutions in 1 country.
Eva MittermairDepartment of Pharmacognosy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria.
Hanspeter KähligDepartment of Organic Chemistry, University of Vienna, Währingerstraße 38, 1090 Vienna, Austria.
Ammar TahirDepartment of Pharmacognosy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria.ORCID 0000-0003-3682-5680
Stefanie RindlerDepartment of Pharmacognosy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria.
Xenia HudecInstitute of Cancer Research, Department of Medicine I, and Comprehensive Cancer Center, Medical University Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Hemma SchuefflInstitute of Cancer Research, Department of Medicine I, and Comprehensive Cancer Center, Medical University Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Petra HeffeterInstitute of Cancer Research, Department of Medicine I, and Comprehensive Cancer Center, Medical University Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Brigitte MarianInstitute of Cancer Research, Department of Medicine I, and Comprehensive Cancer Center, Medical University Vienna, Borschkegasse 8a, 1090 Vienna, Austria.ORCID 0000-0001-7034-5563
Liselotte KrennDepartment of Pharmacognosy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria.
University of Vienna · ATComprehensive Cancer Center Vienna · AT
Funding
Hochschuljubiläumsstiftung der Stadt Wien H-211753/2018
6 · The paper itself
Abstract
The tree fern
Indexed as
Carbon-13 Magnetic Resonance SpectroscopyCaspasesCell Cycle ProteinsCell DeathCell Line, TumorColorectal NeoplasmsDNA Topoisomerases, Type IFernsHumansMethylationPlant RootsProton Magnetic Resonance SpectroscopyTopoisomerase InhibitorsXanthonesCaspasesCell Cycle ProteinsDNA Topoisomerases, Type ITopoisomerase InhibitorsXanthones2-deprenyl-5-O-methyl-7-hydroxy-rhee-diaxanthone B2-deprenyl-5-O-methyl-7-methoxy-rheediaxanthone B2-deprenyl-6-O-methyl-7-hydroxy-rheediaxanthone B2-deprenyl-7-methoxy-rheediaxanthone BmetaxyaceaeMetaxya rostrata
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Methylated Xanthones from the Rootlets of · full record | OpenQuestion